CD79A and allergic disease: The prevention of allergic reactions upon pretreatment with holo-BLG before Bet v 1 sensitization was accompanied by reduced levels of Bet v 1-specific IgG1 and IgE, besides a trend towards lower Bet v 1-specific IgA, and IgG2a levels (Figure 6A).